 |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
 |
|
|
|
||||||
 |
|||||||||
UNYTECH04 Presenting Companies Advanced Resonance Technologies, Inc. (ARTech) is the only company
in the world able to provide polymeric NMR sample tubes that inherently outperform conventional glass sample tubes. For low-field NMR experiments, polymer tubes provide greater mechanical stability, easier sample
recovery, and magnetic susceptibility matching to common solvents and will facilitate acquisition of high-quality spectra. With ARTech tubes it is possible to eliminate 66-80% of the wall thickness, allowing more
sample to occupy an increased volume in the NMR receiver coil, which significantly improves sensitivity without sacrificing tube durability. Applied NanoWorks Applied NanoWorks (ANW) has developed a highly scalable process for manufacturing nanomaterials that are <10nm in size. The process also allows tailoring of particle size
between 10nm and 50nm and is being targeted to two markets; nano-sized metal oxides for the $440M semiconductor planarization market and semiconductor quantum dots for the $3B LED market. ANW's four metal-oxide
materials offer the planarization market improved polishing performance at the same or lower price over current materials. Our semiconductor quantum dots have drastically better price-performance than existing materials
and will become the disruptive technology needed by the white LED market to make this cost effective lighting technology a reality. Cerebral Assessment Systems, LLC Cerebral Assessment Systems, LLC (CAS), is a clinical research organization (CRO) and medical evaluation service specializing in clinical trials of new therapies
for Alzheimer's and other neurodegenerative diseases. CAS's approach to assessing and monitoring patients is such a significant advancement that a patent has been awarded for these unique techniques. The methodology
results in faster data collection and objective analysis of disease progression, thus allowing clinical trials to yield more reliable results produced at less expense than established methods.
Distributed Generation Technologies Jonathan Greene Distributed Generation Technologies (DGT) specializes in the commercialization of
distributed energy generation technology, specifically the development of innovative and patentable multi-fuel technologies that lead to high-margin commercial, industrial, and consumer products. DGT is focusing on the
development of the company's first technology license, a modular bioreactor that pressurizes and purifies natural gas produced from anaerobic digestion of biomass fuels. Dynamic Eye, Inc. Dynamic Eye is developing high-value sunglasses, called E-Clips™, that selectively shield blinding lights from the user's eyes. E-Clips combine sensors, miniaturized
electronics and specialized liquid crystal displays (LCDs) to increase the comfort and safety of the customer. E-Clips™ will display a darkened spot on each lens between each glare source and the user's pupil,
thereby shading pupils from the glare. The rest of the view will have a transmission of about 40%, like normal sunglasses, so the wearer can see without the blinding interference of the glare source. Because
E-Clips™ distinguish between glare sources and the rest of the scene, they can shield the glare to a far greater extent than normal sunglasses. Elecsci Corporation Elecsci Corporation's intellectual property portfolio consists of 7 patents issued, 15 patents pending, and 3 disclosures waiting for review. Elecsci's embedded electron
charge technology has diverse market applications including energy harvesting, MEMS devices, biohazard sensors, consumer products, filters, and components for wireless communications including micro switches, variable
capacitors, and rf resonators. Verification of the underlying science has been demonstrated and low cost manufacturing techniques have been developed. Gendyne Therapeutics, Inc. Gendyne Therapeutics is an early-stage biopharmaceutical company developing nucleic acid delivery systems to serve defined niches in both the cell transfection and
the rapidly emerging RNA Interference (RNAi) therapeutic markets. Our breakthrough cell transfection products have specific in vitro applications for enhancing the delivery of nucleic acids by using patented silica
nanoparticle technology. We aim to fulfill the promise of this new therapeutic approach by collaborating with pharmaceutical and biotechnology industry leaders to develop novel non-viral hybrid encapsulation platforms
for clinically relevant RNAi delivery. Hybrid Silica Technologies, Inc. Hybrid Silica Technologies, Inc., develops and markets fluorescent silica
nanoparticles called "CUDots," and other nanostructured silica materials. These advanced materials have great potential as key components in bioimaging, value-added devices such as sensors, development tools for drug
discovery and other related areas in the life sciences. NIRx Medical Technologies LLC NIRx is a
medical device company that has pioneered the field of Temporal Spectral Imaging (TSI). This fundamentally new noninvasive technology is capable of providing novel insights about integrated body function, early
detection of disease states and effects of pharmaceutical agents. Current areas of opportunity for development include neuroscience investigation, cancer detection and treatment monitoring, particularly breast cancer,
improved long-term care of diabetics, drug discovery and evaluation, and acute care monitoring. The core feature of TSI technology is the ability to explore, in real time, the complex interactions between tissue and its
blood supply through the use of near infrared optical imaging techniques, also known as diffuse optical tomography. OrthoSystems, Inc. OrthoSystems is a biotechnology enterprise applying proprietary patent pending methods to produce OrthoSwitches™ a soluble entity that changes fluorescent in response
to biological macromolecules or organisms. OrthoSwitch,™ OrthoSystems' platform technology, has demonstrated the ability of transducing molecular recognition of biological targets into a real-time (seconds) optical
signal. This technology is very generally applicable when used in combination with other existing biotechnologies. The primary market areas under development are environmental detection of pathogenic organisms in water
supplies, detection of bioterror agents and the development of high throughput screening methods for pharmaceutical lead compounds. OyaGen Inc. OyaGen is
a start-up biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies that seek to exploit breakthrough research originated at both the University of Rochester Medical
Center (URMC) and the Thomas Jefferson University (TJU). OyaGen holds exclusive rights to these important technologies. OyaGen's initial therapeutic focus is a novelapproach to the treatment of Human Immunodeficiency
Virus (HIV). Remarkable Paint Company Re-Markable Paint is a unique, high quality, removable marking paint that is
visually appealing, rainfast, and tolerant to foot traffic. The paint and removing solution are safe chemical protocols that can be used in commercially available spray machines. In addition to being removable,
the paint and removal solution will not damage plants or artificial turf. Therex LLC Therex LLC discovers and develops
drug candidates for the oral and dermal health care markets based upon its proprietary platform pharmaceutical technology that treats topical inflammatory conditions caused or exacerbated by bacterial infections. The
primary disease states Therex is addressing are gingivitis, periodontitis, acne, rosacea and chronic skin wounds such as diabetic foot ulcers, decubitus ulcers (or bed sores) and infections at the site of severe burns. [
|
|||||||||
Home |
Agenda | Companies | Sponsors | Registration | Venue/Travel Copyright 2006 UNYTECH
|